Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bryan Rafferty
Safety, Pharmacokinetics and Pharmacodynamics of Remogliflozin Etabonate, a Novel SGLT2 Inhibitor, and Metformin When Co-Administered in Subjects With Type 2 Diabetes Mellitus
BMC pharmacology & toxicology
Medicine
Pharmacology
Related publications
Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients With Type 2 Diabetes Mellitus
Advances in Therapy
Medicine
Pharmacology
Pharmacokinetics and Pharmacodynamics of Luseogliflozin, a Selective SGLT2 Inhibitor, in Japanese Patients With Type 2 Diabetes With Mild to Severe Renal Impairment
Clinical Pharmacology in Drug Development
Pharmacology
Pharmaceutical Science
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects
Drug Metabolism and Pharmacokinetics
Pharmacology
Pharmaceutical Science
The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Journal of Clinical Pharmacology
Pharmacology
Effective SGLT2 Inhibitor for Patient With Type 2 Diabetes Mellitus (T2DM) and Depression
The Pharmacokinetics and Pharmacodynamics of Alogliptin in Children, Adolescents, and Adults With Type 2 Diabetes Mellitus
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986142, a Novel Reversible BTK Inhibitor, in Healthy Participants
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Ertugliflozin: A New SGLT2 Inhibitor for Type 2 Diabetes
Prescriber
Pharmacology
Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered With Intravenous Morphine in Healthy Adult Subjects
Clinical Drug Investigation
Medicine
Pharmacology
